Atrial fibrillation with Slow Ventricular response as a sign of Digoxin toxicity Secondary to Acute Renal failure.

Authors

  • Selome Yewedalsew
  • Estrella Roffe
  • Meron
  • Tilahun Jiru
  • Abaynesh Haftu
  • Abeselom Ashenafi
  • Gemechis Direba
  • Asmamaw Abebe
  • Mohammed Shuaibu
  • Hossein Kalantari
  • Getaw Worku Hassen a:1:{s:5:"en_US";s:54:"New York Medical College, Metropolitan Hospital Center";}

DOI:

https://doi.org/10.58904/2024/97

Keywords:

ECG, digoxin, renal failure, toxicity

Abstract

Digoxin is a cardiac glycoside that has been used for centuries for atrial fibrillation (AFib) and congestive heart failure (CHF). Digoxin has a narrow therapeutic index with a potential for toxicity that can be life-threatening1-5. Toxicity can result from accidental or intentional overdose, renal failure, and/or hypokalemia. Cardiac manifestations of digoxin toxicity cause dysrhythmias of different types2,6. Bidirectional ventricular tachycardia is a specific dysrhythmia in the setting of digitalis toxicity, but AFib with slow ventricular response (SVR) is another digoxin toxicity-related dysrhythmia7. Here, we report AFib with SVR as a sign of digoxin toxicity secondary to acute renal failure (ARF).

Downloads

Published

2024-10-10

How to Cite

Yewedalsew, S., Roffe, E., Tesfaye, M., Jiru, T. ., Haftu, A. ., Ashenafi, A. ., … Hassen, G. W. (2024). Atrial fibrillation with Slow Ventricular response as a sign of Digoxin toxicity Secondary to Acute Renal failure. Pan African Journal of Emergency Medicine and Critical Care, 2(2). https://doi.org/10.58904/2024/97

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.